Navigation Links
Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession
Date:6/25/2009

ay qualify for assistance," said Williams. "As a patient who must cope every day with the effects of multiple sclerosis, I understand only too well the importance of having access to the medicine you need."

More than 1,300 national, state and local partners are working with America's pharmaceutical research companies to spread the word about the program. Trained specialists work with doctors, pharmacists, health care providers and community groups, educating them on the process and use of the PPA's easy-to-access Web site and toll-free number.

To find out if there are patient assistance programs that may meet their needs, patients should call toll-free 1-888-4PPA-NOW (1-888-477-2669) to speak with a trained specialist or visit www.pparx.org.


'/>"/>
SOURCE Partnership for Prescription Assistance
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Verenium and Add Food Service GmbH Announce Commercial Distribution Partnership for Fuelzyme(R) and Veretase(TM) Enzymes
2. GfK Asia Expands into Korea Optics Industry Partnership Network
3. KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter
4. Partnership for Prescription Assistance Prepared to Help Nebraska Workers Hurt by Recession
5. Accelerated Development of New Treatment for Multi Drug-Resistant Tuberculosis: TB Alliance and Tibotec Announce Unique Partnership to Develop TMC207
6. CBay Announces the Reseller Partnership Program
7. VaxAmerica Enters Partnership with Emeritus Senior Living
8. National Quality Forum Welcomes Dr. Thomas Valuck, SVP of Strategic Partnerships
9. Tasty Baking Company Supports the Fight Against Childhood Cancer Through Partnership with Alexs Lemonade Stand Foundation
10. Partnership for Prescription Assistance Prepared to Help Wyoming Workers Hurt by Recession
11. Partnership for Prescription Assistance Prepared to Help Idaho Workers Hurt by Recession

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Older males saw their odds drop by 63 percent wi..., MONDAY, Nov. 23 (HealthDay News) -- Moderate-to... or tennis may help reduce stroke risk in older me...tudy included almost 3,300 men and women, average ...ine years. During that time, there were 238 stroke...
(Date:11/23/2009)... Dr. Bernadine Healy, first woman to head the age...DAY, Nov. 23 (HealthDay News) -- The fallout from ...n delay the start of routine mammogram testing for...e U.S. National Institutes of Health advising wome...powerfully ignore them, because unequivocally this...
(Date:11/23/2009)... ,, CENTERCITY,Minn.,Nov.23/PRNewswire/--Haz...treatmentcenter,todayannouncedtheleadershipteamfor...bedfacilityinNaplesisscheduledtoopeninlateMarch201...sforadults,includingafullarrayoffamilyandoutpatien...ecutivedirectorofHazelden,sfacilityinNaples,withBr...
(Date:11/23/2009)... ,, $4Million Alliance ProgramSupportsFut...nshipGuideAvailableat www.Allia n ceS ...ire-USNewswire/--"Mr.President,youcancountusin.Wit...lianceisproudtobeapartofEducatetoInnovate,"saidAdo...ceforHispanicHealth,afterattendingaWhiteHousemeeti...
(Date:11/23/2009)... ,, TUCSON,Ariz.,Nov.23/PRNewswire/--Cortiva...apyWorkshoponSunday,Dec.6from1-3p.m.attheschool,s6...ortunityforparticipantstolearnandpracticebasicmass...dCortivaInstituteTucsonisgrowingrightalongwithit,"...n. ,, Infact,theU.S.DepartmentofLabor,s2009-201...
Breaking Medicine News(10 mins):Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2
... Illinois will host a first-of-its-,kind celebrati...s and,friends. The BIG Night Out - Indulgence for...om 6:30 p.m. to 10:00 p.m. in the Great Hall of Ch...olates,scrumptious hors d,ouevres and martinis mad...
... /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals,...t signed amended,agreements with Smith & Nephew wo...icoat(TM) dressings with SILCRYST(TM) nanocrystall...o grant,NUCRYST exclusive manufacturing rights, pl...
... Oct. 1 UTC Power, a,United Technologies Corp. (N...ed Dome- Tech Group, a national energy consulting ...y. Financial terms were not disclosed. Dome-Tech ...d carbon footprint reduction, smart energy,procure...
...Capabilities that Help Patients Achieve Optimum He....,(Nasdaq: VTIV ) today announced that it has lau...Outcomes, with a focus on helping pharmaceutical,c... wins -,the healthcare providers, the pharmaceutic...
... Increasing New Jersey Life Sciences Jobs With ... PARSIPPANY, N.J., Oct. 1 Daiichi Sankyo, Inc. ha...s and rapidly increasing its,staffing since 2002 t...cal companies experiencing steady and sustained,gr...
...ty Awareness Month, WHITE PLAINS, N.Y., Oct. 1 M...h the March of Dimes to help give,every baby their...ternity,a national sponsor of the March of Dimes P...to save babies from,premature birth. "We are plea...
Other Medicine News:Health News:Y-ME Illinois Hosts the First-Ever 'BIG Night Out' - Indulgence for a Cause 2Health News:NUCRYST and Smith & Nephew Revise Agreements 2Health News:NUCRYST and Smith & Nephew Revise Agreements 3Health News:NUCRYST and Smith & Nephew Revise Agreements 4Health News:NUCRYST and Smith & Nephew Revise Agreements 5Health News:NUCRYST and Smith & Nephew Revise Agreements 6Health News:NUCRYST and Smith & Nephew Revise Agreements 7Health News:UTC Power Acquires Dome-Tech Group 2Health News:inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes 2Health News:inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes 3Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 3Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 4Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 5Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 6Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 7Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 8Health News:Motherhood(R) Maternity Joins March of Dimes to Give Babies a Healthy Start in Life 2
(Date:11/23/2009)...swire-FirstCall/--CordBloodAmerica,Inc.(OTCBulleti...tioncompany( http://www.cordblood-america.com )foc...iologicalinsurancepolicy,tofamiliesnationwideandin...nterviewwithCEOandco-founderMatthewSchisslerisnowa...p.tv/file/2875811 . ,, Intheinterview,Mr.Schiss...
(Date:11/23/2009).../PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq: VR...itspartnerRoche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),willc...eongoingphase2btrialofRG7128,afirst-in-classnucleo...nichepatitisCvirus(HCV)infection.Thedecisionwasrea...ringCommittee(DMC)ofallavailablesafetydatafromthef...
(Date:11/23/2009)...PRNewswire-FirstCall/--RaptorPharmaceuticalCorp.("...edresultsfromaPhase2bclinicaltrialofitsproprietary...)inpatientswithnephropathiccystinosis("cystinosis"...nDiego("UCSD")GeneralClinicalResearchCenter,evalua...dynamicsofasingledoseofDRCysteamineinninecystinosi...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5FDA Panel Weighs Approving HPV Vaccine for Males 56544 1FDA Panel Weighs Approving HPV Vaccine for Males 56544 2FDA Panel Weighs Approving HPV Vaccine for Males 56544 3CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 1CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 2CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 3CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 4CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 5Cash For Crows Feet Program Offers Effective and Affordable Laser Skin Treatments 56536 1Cash For Crows Feet Program Offers Effective and Affordable Laser Skin Treatments 56536 2
... Efficacy of Treating Patients with ...nd YONGIN-SI, South Korea, July 22 ,Jennerex, Inc....South,Korean partner Green Cross Corp., announced ...trial of its first-in-class lead product JX-594,de... resulted in clear,anti-cancer efficacy in patient...
...rapy and pegylated enzyme produces significantl... - - Pegylated enzyme well tolera...Inc. (Nasdaq: HALO ), a biopharmaceutical company... the extracellular matrix, today,announced the pre... data,for its pegylated-rHuPH20 enzyme (PEGPH20) a...
Other Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5
HSV 2 IgG II ELISA
Avci Foreign Body Forceps 20 gauge / 0.9 mm
Microforceps: Horizontal Subretinal
Microforceps: Claes ILM Forceps
Medicine Products: